ViralClear Pharmaceuticals Partners With Albany Molecular Research (AMRI) on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of COVID-19

Press/Media: Expert Comment

PeriodJul 8 2020

Media coverage

2

Media coverage

  • TitleViralClear Pharmaceuticals Partners With Albany Molecular Research (AMRI) on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of COVID-19
    Media name/outletIndia Pharma News
    CountryIndia
    Date7/8/20
    PersonsCheng Huang, Slobodan Paessler, John Manning
  • TitleBioSig Technologies: ViralClear Pharmaceuticals partners with Albany Molecular Research on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19
    Media name/outletIndia Pharma News
    CountryIndia
    Date7/8/20
    PersonsCheng Huang, Slobodan Paessler, John Manning

Keywords

  • COVID-19